Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.8K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.8K
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

2.7K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design, Physicochemical Characterization, and Antibacterial Activity of Freeze-Dried Sodium Alginate Sponges Loaded With Amazonian Oil (Carapa guianensis Aubl.) and a Mn(II)-Phenanthroline Complex for Potential Use in Topical Applications.

Chemistry & biodiversity·2026
Same author

Engineering Alginate Membranes With Green Propolis-Coated Silver Nanoparticles for Potential Use in Wound Dressing.

Chemistry & biodiversity·2026
Same author

Preparation, Characterization, and Keratinocyte Cell Viability of a β‑Cyclodextrin-Myrcene Complex Intended for Skin Application.

ACS omega·2026
Same author

Unlocking Biomedical Potential of the [Cu(l‑isoleucine)(1,10-phenanthroline)(H<sub>2</sub>O)]Cl·2H<sub>2</sub>O Complex: A Comprehensive Study of Synthesis, Spectroscopic Analyses, Antitumor Efficacy, and Computational Insights.

ACS omega·2026
Same author

Artificial intelligence in drug research and development: a review of methods and applications in drug repurposing.

Briefings in bioinformatics·2026
Same author

Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological disease.

Science translational medicine·2026

Related Experiment Video

Updated: Oct 12, 2025

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

18.1K

Lipid Nanocarriers for Hyperproliferative Skin Diseases.

Eliana B Souto1, Ana L R de Souza2, Fernanda K Dos Santos2

  • 1CEB-Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.

Cancers
|November 27, 2021
PubMed
Summary

Lipid nanocarriers enhance topical treatment for hyperproliferative skin diseases (HSD). These formulations improve the delivery of poorly soluble anti-proliferative drugs, increasing effectiveness and reducing side effects for various skin conditions.

Keywords:
antiproliferative drugshyperproliferative skin diseaseslipid nanoparticlesliposomesskin cancer

More Related Videos

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.1K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.3K

Related Experiment Videos

Last Updated: Oct 12, 2025

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

18.1K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.1K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.3K

Area of Science:

  • Dermatology
  • Nanotechnology
  • Pharmacology

Background:

  • Hyperproliferative skin diseases (HSD) encompass conditions like skin cancers and pre-cancerous lesions.
  • Current treatments utilize diverse anti-proliferative agents (e.g., 5-fluorouracil, methotrexate).
  • Many effective drugs exhibit poor aqueous solubility, limiting topical skin permeation and efficacy.

Purpose of the Study:

  • To highlight the advantages of using lipid nanocarriers for treating HSD.
  • To demonstrate the potential of lipid nanoparticles and liposomes in enhancing drug delivery.
  • To explore the application of these nanocarriers for a wide range of chemically diverse drugs.

Main Methods:

  • Review of literature on lipid nanocarriers (nanoparticles, liposomes) for topical drug delivery.
  • Analysis of drug properties, specifically aqueous solubility and skin permeation challenges.
  • Discussion of formulation strategies for incorporating anti-proliferative agents into lipid nanocarriers.

Main Results:

  • Lipid nanocarriers significantly improve the incorporation and skin permeation of poorly soluble anti-proliferative drugs.
  • Formulations offer enhanced therapeutic effectiveness for HSD.
  • Reduced systemic absorption and localized side effects are potential benefits.

Conclusions:

  • Lipid nanocarriers represent a promising strategy for optimizing topical treatment of HSD.
  • These advanced delivery systems can overcome solubility limitations of key anti-proliferative drugs.
  • Further research into lipid-based formulations can lead to improved patient outcomes in dermatology.